A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval
Clinical trial NCT03577275 · COMPLETED
Trial details
- NCT number
- NCT03577275
- Sponsor
- NorthSea Therapeutics B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-15
- Primary completion
- 2018-09-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.